152 related articles for article (PubMed ID: 38195889)
21. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
Baumgart A; Mazur PK; Anton M; Rudelius M; Schwamborn K; Feuchtinger A; Behnke K; Walch A; Braren R; Peschel C; Duyster J; Siveke JT; Dechow T
Oncogene; 2015 Jan; 34(5):578-88. PubMed ID: 24509876
[TBL] [Abstract][Full Text] [Related]
22. The Mediator Med23 controls a transcriptional switch for muscle stem cell proliferation and differentiation in muscle regeneration.
Fang Y; Yuan C; Li C; Lu C; Yu W; Wang G
Cell Rep; 2024 May; 43(5):114177. PubMed ID: 38691453
[TBL] [Abstract][Full Text] [Related]
23. The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.
Yao X; Tang Z; Fu X; Yin J; Liang Y; Li C; Li H; Tian Q; Roeder RG; Wang G
EMBO J; 2015 Dec; 34(23):2885-902. PubMed ID: 26330467
[TBL] [Abstract][Full Text] [Related]
24. miR-301a promotes lung tumorigenesis by suppressing Runx3.
Li X; Zhong M; Wang J; Wang L; Lin Z; Cao Z; Huang Z; Zhang F; Li Y; Liu M; Ma X
Mol Cancer; 2019 May; 18(1):99. PubMed ID: 31122259
[TBL] [Abstract][Full Text] [Related]
25. Mediator Med23 deficiency enhances neural differentiation of murine embryonic stem cells through modulating BMP signaling.
Zhu W; Yao X; Liang Y; Liang D; Song L; Jing N; Li J; Wang G
Development; 2015 Feb; 142(3):465-76. PubMed ID: 25564654
[TBL] [Abstract][Full Text] [Related]
26. Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway.
Hou X; Zhou C; Liang Z; Qiu H; Zhou Z; Zheng H; Li Z; Wang Y; Qi X; Lu L; Cao Y; Zheng J
Phytomedicine; 2023 Dec; 121():155093. PubMed ID: 37783131
[TBL] [Abstract][Full Text] [Related]
27. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.
Chu Y; Gómez Rosso L; Huang P; Wang Z; Xu Y; Yao X; Bao M; Yan J; Song H; Wang G
Cell Res; 2014 Oct; 24(10):1250-65. PubMed ID: 25223702
[TBL] [Abstract][Full Text] [Related]
28. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
29. The mediator subunit Med23 contributes to controlling T-cell activation and prevents autoimmunity.
Sun Y; Zhu X; Chen X; Liu H; Xu Y; Chu Y; Wang G; Liu X
Nat Commun; 2014 Oct; 5():5225. PubMed ID: 25301163
[TBL] [Abstract][Full Text] [Related]
30. Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells.
Chen X; Zhao J; Gu C; Cui Y; Dai Y; Song G; Liu H; Shen H; Liu Y; Wang Y; Xing H; Zhu X; Hao P; Guo F; Liu X
Nat Commun; 2018 Sep; 9(1):3746. PubMed ID: 30218073
[TBL] [Abstract][Full Text] [Related]
31. Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation.
Yin JW; Liang Y; Park JY; Chen D; Yao X; Xiao Q; Liu Z; Jiang B; Fu Y; Bao M; Huang Y; Liu Y; Yan J; Zhu MS; Yang Z; Gao P; Tian B; Li D; Wang G
Genes Dev; 2012 Oct; 26(19):2192-205. PubMed ID: 22972934
[TBL] [Abstract][Full Text] [Related]
32. Mediator complex regulates alternative mRNA processing via the MED23 subunit.
Huang Y; Li W; Yao X; Lin QJ; Yin JW; Liang Y; Heiner M; Tian B; Hui J; Wang G
Mol Cell; 2012 Feb; 45(4):459-69. PubMed ID: 22264826
[TBL] [Abstract][Full Text] [Related]
33. Med23 Regulates Sox9 Expression during Craniofacial Development.
Dash S; Bhatt S; Falcon KT; Sandell LL; Trainor PA
J Dent Res; 2021 Apr; 100(4):406-414. PubMed ID: 33155500
[TBL] [Abstract][Full Text] [Related]
34. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.
Kerr EM; Gaude E; Turrell FK; Frezza C; Martins CP
Nature; 2016 Mar; 531(7592):110-3. PubMed ID: 26909577
[TBL] [Abstract][Full Text] [Related]
35. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
36. MED23 in endocrinotherapy for breast cancer.
Lin B; Zhang L; Li D; Sun H
Oncol Lett; 2017 Jun; 13(6):4679-4684. PubMed ID: 28588722
[TBL] [Abstract][Full Text] [Related]
37. Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.
Xia M; Chen K; Yao X; Xu Y; Yao J; Yan J; Shao Z; Wang G
Cell Rep; 2017 Aug; 20(8):1794-1804. PubMed ID: 28834744
[TBL] [Abstract][Full Text] [Related]
38. An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities.
Yang Y; Li C; Chen Z; Zhang Y; Tian Q; Sun M; Zhang S; Yu M; Wang G
Nucleic Acids Res; 2023 Mar; 51(5):2137-2150. PubMed ID: 36718943
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.
Shi J; Han Q; Zhao H; Zhong C; Yao F
Mol Carcinog; 2014 Oct; 53(10):833-40. PubMed ID: 23625751
[TBL] [Abstract][Full Text] [Related]
40. B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy.
Zhao Y; Cao Y; Chen Y; Wu L; Hang H; Jiang C; Zhou X
Immunology; 2021 Nov; 164(3):507-523. PubMed ID: 34115389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
